Stay updated on IcoSema vs. Semaglutide in Type 2 Diabetes Clinical Trial
Sign up to get notified when there's something new on the IcoSema vs. Semaglutide in Type 2 Diabetes Clinical Trial page.

Latest updates to the IcoSema vs. Semaglutide in Type 2 Diabetes Clinical Trial page
- Check3 days agoNo Change Detected
- Check10 days agoNo Change Detected
- Check17 days agoChange DetectedA new revision entry, v3.7.0, was added to the study history, while the prior revision v3.6.6 was removed from the list.SummaryDifference0.1%

- Check38 days agoChange DetectedA new revision entry 'Revision: v3.6.6' was added to the study record history, replacing the previous revision, indicating an updated version of the page data.SummaryDifference0.1%

- Check59 days agoChange DetectedThe record history now shows a new revision version v3.6.5, replacing the previous v3.6.4.SummaryDifference0.1%

- Check74 days agoChange DetectedThe revision history now shows a new entry Revision: v3.6.4 and removes Revision: v3.6.3, updating the page's revision history metadata.SummaryDifference0.1%

- Check95 days agoChange DetectedThe page's revision label in the history section updated from v3.6.2 to v3.6.3, representing a minor update to the page's revision tracking.SummaryDifference0.1%

- Check102 days agoChange DetectedThe record’s revision label was updated from v3.6.0 to v3.6.2. This indicates a new revision of the study record.SummaryDifference0.1%

Stay in the know with updates to IcoSema vs. Semaglutide in Type 2 Diabetes Clinical Trial
Enter your email address, and we'll notify you when there's something new on the IcoSema vs. Semaglutide in Type 2 Diabetes Clinical Trial page.